boosting Oncology analysis with built-in KRAS Assay providers and RAS Assays
from the promptly evolving field of oncology investigation, exact and efficient mutation screening is crucial for producing focused therapies. The KRAS companies System performs a pivotal job With this landscape by supplying extensive options for KRAS mutation profiling and Examination. KRAS mutations, found in close to 95% of RAS-related oncogenic